Patents by Inventor Cynthia Bamdad

Cynthia Bamdad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDIA FOR STEM CELL PROLIFERATION AND INDUCTION
    Publication number: 20230287338
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Application
    Filed: January 12, 2023
    Publication date: September 14, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20230279141
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: June 8, 2021
    Publication date: September 7, 2023
    Inventors: Cynthia BAMDAD, Benoit SMAGGHE
  • HUMANIZED ANTI-MUC1* ANTIBODIES
    Publication number: 20230279142
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: September 7, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Humanized anti-MUC1* antibodies
    Patent number: 11746159
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: September 5, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20230242678
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: June 27, 2021
    Publication date: August 3, 2023
    Inventors: Cynthia BAMDAD, Benoit SMAGGHE
  • METHODS FOR DERIVING DOPAMINERGIC NEURONS FROM PLURIPOTENT STEM CELLS
    Publication number: 20230242874
    Abstract: The present application discloses a method of producing dopaminergic neurons from human stem cells by adding or increasing concentration of vitamin into neuro basal media at approximately Day 20+/?3 of a protocol for differentiating pluripotent stem cells into dopaminergic neurons.
    Type: Application
    Filed: June 28, 2021
    Publication date: August 3, 2023
    Inventors: Cynthia BAMDAD, Kevin R. YI, Scott T. MOE, Thomas JEON
  • Method of treating an NME7 expressing cancer with a peptide
    Patent number: 11702483
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: July 18, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • HUMANIZED ANTI-MUC1* ANTIBODIES
    Publication number: 20230183373
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: June 15, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Media for stem cell proliferation and induction
    Patent number: 11591565
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: February 28, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • NME VARIANT SPECIES EXPRESSION AND SUPPRESSION
    Publication number: 20230049461
    Abstract: The present application discloses a method for generating less mature cells from starting cells including inducing the starting cells to revert to a less mature state including increasing the amount of an NME family member whose multimerization state is the biologically active state or decreasing the relative amount of an NME family member whose multimerization state is the biologically inactive state.
    Type: Application
    Filed: September 27, 2022
    Publication date: February 16, 2023
    Inventor: Cynthia BAMDAD
  • MUC1* antibodies
    Patent number: 11560435
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: January 24, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • ANTI-CANCER PEPTIDE
    Publication number: 20220289865
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: April 12, 2022
    Publication date: September 15, 2022
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20220259324
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: August 3, 2021
    Publication date: August 18, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • METHODS FOR CULTURING STEM AND PROGENITOR CELLS
    Publication number: 20220252604
    Abstract: The present application describes a method of culturing, expanding or growing stem or stem-like cells or induced pluripotent stem cells on a surface, including attaching the cells to the surface through a ligand that binds to the surface and the cells.
    Type: Application
    Filed: June 21, 2021
    Publication date: August 11, 2022
    Inventor: Cynthia Bamdad
  • AGENTS FOR DIFFERENTIATING STEM CELLS AND TREATING CANCER
    Publication number: 20220242823
    Abstract: The present application discloses a method for identifying an agent for the treatment or prevention of cancer or metastatic cancer comprising the steps of contacting stem cell with a potential agent, and identifying an agent that induces differentiation, or inhibits stem cell pluripotency or growth of the stem cell, wherein such agent is determined to be an anti-cancer agent.
    Type: Application
    Filed: October 28, 2021
    Publication date: August 4, 2022
    Inventors: Cynthia BAMDAD, Scott MOE
  • METHOD FOR ENHANCING TUMOR GROWTH
    Publication number: 20220193270
    Abstract: The present application discloses a method of testing for efficacy of a potential drug agent against cancerous cells in a mammal, including generating the cancer cells in a mammal; contacting the cancer cells with a potential drug agent by administering the potential drug agent to the mammal; and measuring effect of the potential drug agent on the cancer cells, wherein reduction of number of cancer cells in the mammal is indicative of efficaciousness of the potential drug agent against cancerous cells.
    Type: Application
    Filed: October 4, 2021
    Publication date: June 23, 2022
    Inventor: Cynthia BAMDAD
  • ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF
    Publication number: 20220184120
    Abstract: The present application discloses an antibody, or fragment thereof, for the diagnosis, treatment or prevention of cancers wherein the antibody specifically binds to the PSMGFR peptide (SEQ ID NO:2) or a fragment thereof of the peptide.
    Type: Application
    Filed: July 12, 2021
    Publication date: June 16, 2022
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • NME INHIBITORS AND METHODS OF USING NME INHIBITORS
    Publication number: 20220089779
    Abstract: The present application discloses inhibitors of NME family of proteins.
    Type: Application
    Filed: May 3, 2021
    Publication date: March 24, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia BAMDAD, Benoit Smagghe
  • METHOD FOR DIAGNOSING AND TREATING CANCER USING NAÏVE STATE STEM CELL SPECIFIC GENES
    Publication number: 20210308213
    Abstract: The present application discloses a method for converting a cell to naïve state stem cells comprising contacting the cell to be converted with an NME protein.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 7, 2021
    Inventors: Cynthia Bamdad, Benoit Smagghe, Mark G. Carter
  • AGENTS FOR TREATING CANCER AND METHODS FOR IDENTIFYING SAID AGENTS
    Publication number: 20210299109
    Abstract: The present application discloses a method for identifying an agent for the treatment or prevention of cancer or metastatic cancer comprising the steps of contacting stem cell with a potential agent, and identifying an agent that induces differentiation, or inhibits stem cell pluripotency or growth of the stem cell, wherein such agent is determined to be an anti-cancer agent.
    Type: Application
    Filed: December 19, 2018
    Publication date: September 30, 2021
    Inventors: Cynthia BAMDAD, Scott MOE